Am J Transplant, Volume 19, Suppl 3 Archives - Page 200 of 214 - ATC Abstracts

2019 American Transplant Congress
The Association of BK Virus Infection and Risk of Subsequent Cytomegalovirus Infection after Renal Transplant
M. R. Jorgenson, J. L. Descourouez, B. Lyu, B. C. Astor, C. M. Saddler, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Cytomegalovirus (CMV) and BK polyoma virus are opportunistic infections after renal transplant (RTX) that have negative allograft outcomes. Immunosuppressive reduction is the mainstay of…
2019 American Transplant Congress
Characteristics of Patients with Early vs Late BK Viremia after Kidney Transplantation
S. Rehman¹, J. Pryor², A. Olyaei³, M. Stack¹, D. Norman¹, J. Lockridge¹
¹Medicine/Nephrology, Oregon Health and Science University, Portland, OR, ²Oregon Health and Science University, Portland, OR, ³Pharmacy, Oregon Health and Science University, Portland, OR
*Purpose: To describe the characteristics of patients presenting with late BK viremia (>1 year after transplant) and compare to early BK viremia*Methods: This study was…
2019 American Transplant Congress
Early Allograft Dysfunction in High Acuity Liver Transplant Recipients
T. Ito, M. Lu, A. Murray, D. S. Graham, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Organ recipient matching in Liver Transplantation (LT) has become ever-more challenging with the ongoing organ scarcity and increasing patient acuity. While the notion that…
2019 American Transplant Congress
Liver Transplant Candidates Derive a Survival Benefit from Accepting a Macrosteatotic Liver
K. Jackson, M. Bowring, C. Haugen, C. Holscher, L. Liyanage, S. Ottmann, B. Philosophe, A. Massie, D. Segev, A. Cameron, J. Garonzik-Wang
Johns Hopkins University, Baltimore, MD
*Purpose: Accepting a liver with macrosteatosis might increase the risk of adverse post-transplant outcomes, however candidates who decline must then wait for an uncertain future…
2019 American Transplant Congress
Liver Transplantation in Children with Type 1 and Type 2 Autoimmune Hepatitis
I. G. Roepe, J. A. Goss, T. Miloh
Department of Student Affairs, Baylor College of Medicine, Houston, TX
*Purpose: Autoimmune Hepatitis (AIH) can be defined as type 1 and type 2 based on autoantibodies. Liver transplant (LT) may be indicated for chronic liver…
2019 American Transplant Congress
Lung Allocation Score Should Be Implemented in China
C. Ju, Q. Lian, B. Wei, X. Xu, R. Chen, J. He
State Key Lab of the Respiratory Disease, Guangzhou Institute of Respiratory Disease, Guangzhou, China
*Purpose: Lung transplantation (LTx) is an effective treatment for patients with end stage of respiratory disease. Two of the major candidates are patients with chronic…
2019 American Transplant Congress
Clinical Outcomes of Using mTOR Inhibitors with Reduced Dose of Calcineurin Inhibitors in Lung Transplant Recipients: A Single Center Experience
M. Frawley¹, J. Leedy¹, A. James¹, A. Salter¹, V. Rusanov²
¹Department of Pharmacy, UAB Hospital, Birmingham, AL, ²Division of Pulmonary, Allergy, and Critical Care Medicine, UAB Hospital, Birmingham, AL
*Purpose: The use of mammalian target of rapamycin inhibitors (mTORi) in cardiothoracic transplantation has significantly increased over the past decade. Several recent clinical trials have…
2019 American Transplant Congress
Outcome Differences in Urine Leak Repair Modality Post Kidney Transplantation
J. Buggs¹, V. Gamarra², E. Rogers¹, R. Watson¹, J. Sokolich¹, H. Pearson¹, J. Huang¹, A. Kumar², V. Bowers¹
¹Tampa General Hospital, Tampa, FL, ²University of South Florida, Tampa, FL
*Purpose: The purpose of this study was to determine differences in outcomes of urine leak treatment modalities post kidney transplantation comparing results of foley catheter,…
2019 American Transplant Congress
Performance Improvement Initiative: Ambulatory Tool to Improve Tacrolimus Intrapatient Variability (IPV) Monitoring in Kidney & Liver Transplant Recipients
T. E. Kaiser¹, N. S. Ejaz¹, S. Tremblay¹, N. J. Parrish², S. Schinasi², J. Harris², A. Govil¹, N. Anwar¹, R. R. Alloway¹
¹University of Cincinnati, Cincinnati, OH, ²UC Health, Cincinnati, OH
*Purpose: High tacrolimus (TAC) intrapatient variability (IPV) is associated with poorer outcomes. Manual monitoring of TAC IPV is labor intensive and not always feasible. As…
2019 American Transplant Congress
Impact of Case Scheduling on Hospital Cost and Length of Stay in Living Donor Kidney Recipients
J. Yu¹, L. A. Dageforde², M. B. Doyle¹, A. S. Khan¹, W. C. Chapman¹, Y. Lin¹, S. Shenoy¹, T. Alhamad³, T. A. Horwedel⁴, J. R. Wellen¹
¹Surgery, Washington University School of Medicine, St. Louis, MO, ²Surgery, Massachusetts General Hospital, Boston, MA, ³Medicine, Washington University School of Medicine, St. Louis, MO, ⁴Barnes-Jewish Hospital, St. Louis, MO
*Purpose: In an effort to optimize patient care and cost efficiency, we investigated if living donor kidney transplant (LDKT) recipients incurred any difference in hospital…